Us Weekly15d
I Used to Struggle to Line My Lips — Until I Tried Rhode’s New Peptide Lip Shape
Turns out it was the former. As soon as I got my hands on Rhode’s new Peptide Lip Shape, I transformed into a modern-day Michelangelo. (Except instead of sculpting marble, I became a pro lip ...
Becker's Hospital Review16d
GLP-1 drug approvals: A breakdown
As of Jan. 29, the FDA has approved more than a dozen glucagon-like peptide-1 receptor agonists for diabetes, weight loss, cardiovascular disease and other indications.
The Lancet18d
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
UPI24d
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
The medications are known as glucagon-like peptide-1 receptor agonists (GLP-1RA) and include Mounjaro and Zepbound, which are injectables. They lower blood sugar and energy intake by activating ...
C&EN24d
Effect of Lipidation on the Structure, Oligomerization, and Aggregation of Glucagon-like Peptide 1
Attribution (BY): Credit must be given to the creator. Lipidated analogues of glucagon-like peptide 1 (GLP-1) have gained enormous attention as long-acting peptide therapeutics for type 2 diabetes and ...
New York Post24d
Massive new study finds drugs like Ozempic affect 175 conditions — including a few surprises
A comprehensive new study confirmed that GLP-1 medications such as Ozempic and Mounjaro have myriad health benefits — even more than previously thought. Analyzing the medical records of roughly ...
Seeking Alpha24d
GLP-1 weight loss drugs linked to a wide range of health benefits and risks: study
A new peer-reviewed study based on data from nearly 2M individuals highlights a wide range of clinical benefits and risks, including several newly found conditions linked to the GLP-1 class of ...
AOL25d
Largest-ever Ozempic and GLP-1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 receptor agonists. All the participants, who were followed for a median ...
CBC.ca25d
Ozempic could also help fight dementia but raise other health risks, study says
The class of medications called GLP-1 agonists mimic the actions of a natural hormone that helps curb appetite and slows digestion. The GLP-1 medications approved by Health Canada include Ozempic ...
Medical News Today25d
GLP-1 drugs linked to lower dementia risk, higher risk of kidney, stomach issues
Iuliia Burmistrova/Getty Images The use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for weight loss has been greatly increasing. Past studies show there are positive and negative ...
Healthline25d
GLP-1 Drugs Benefit Brain and Heart Health, but May Cause Kidney, GI Issues
Share on Pinterest GLP-1 drugs may improve brain and heart health but could cause problems for the kidneys and pancreas, according to a new study. FreshSplash/Getty Images Researchers report that ...
CNN25d
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...